Skip to main content

Opioids News

News
The US Department of Health and Human Services (HHS) has released a guide for clinicians detailing the discontinuation of long-term opioid analgesics.1 “Compiled from published guidelines and practices endorsed in the peer-reviewed literature, the Guide covers important issues to consider when…
News
By Reuters Staff (Reuters) - The U.S. Food and Drug Administration and the Drug Enforcement Administration (DEA) jointly issued warning letters to four online networks for illegally marketing unapproved and misbranded versions of opioid medicines, the agencies said. The networks which were issued…
News
By Lisa Rapaport (Reuters Health) - Despite state laws expanding access to the opioid-overdose antidote naloxone without a prescription, a new study suggests that many pharmacies don't stock the drug or dispense it to young people who need it. In the 10 U.S. states with the most opioid overdose…
News
By Tom Hals and Nate Raymond (Reuters) - Oxycontin maker Purdue Pharma LP on Tuesday told a bankruptcy judge it hopes to broaden support for a proposed settlement of 2,600 lawsuits alleging it fueled the U.S. opioid crisis, but opponents of the deal highlighted looming legal battles. A lawyer…
News
Efforts to optimize opioid prescribing and pain treatment after surgery should consider the interacting perspectives of the patient, the perioperative team, and the pharmacist, advises a study published in the American Journal of Health-System Pharmacy.  Researchers reviewed the literature for…
News
By Lisa Rapaport (Reuters Health) - About one in five kids are prescribed opioids after common pediatric surgeries, but a new study suggests they may do just as well with alternative pain relievers like acetaminophen or ibuprofen. From 1999 to 2016, opioid-related overdoses rose by 250% among…
News
By Nate Raymond (Reuters) - An Oklahoma judge on Monday found Johnson & Johnson liable for fueling an opioid epidemic in the state by deceptively marketing painkillers, and ordered the drugmaker to pay damages of $572 million. The damages awarded by Judge Thad Balkman of Cleveland County…
News
By Reuters Staff NEW YORK (Reuters Health) - The novel mu-opioid-receptor agonist NKTR-181 appears to provide long-term pain relief in patients with chronic low-back pain (CLBP), according to results from the uncontrolled, open-label SUMMIT-08 LTS study. NKTR-181 is designed to have a reduced…
News
For the first time, the US Preventive Services Task Force (USPSTF) has issued a draft statement recommending primary care providers to screen for illicit drug use in adults aged 18 years or older.1 The statement serves as a pending update to the USPSTF’s 2008 recommendation, which stated that…
News
By Will Boggs MD NEW YORK (Reuters Health) - Naltrexone may be effective for treating opioid use disorder (OUD) in pregnant women who choose to completely detoxify off opioid drugs, researchers report. "How this study can change future practice is to give some pregnant women the option to choose…
Back to Top